EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Transcriptomic Analysis of Oral Squamous Cell Carcinoma with Progressive Cisplatin Resistance

Dieila Giomo de Lima iD, Gabriell Bonifácio Borgato, Felipe Luz Torres Silva iD, André Schwambach Vieira, Alessandro Santos Farias, Gustavo Narvaes Guimarães iD, Ana Paula de Souza iD

International Journal of Molecular Sciences · 18.08.2026 · 27 (16) · 7366

DOI: 10.3390/ijms27167366 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.08.2026. Verfasst von Dieila Giomo de Lima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Department of Biosciences, Piracicaba Dental School, University of Campinas-UNICAMP, Piracicaba 13414-903, SP, Brazi…. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapy resistance remains a major cause of cancer-related mortality. Cisplatin (cis-diamminedichloroplatinum, CDDP) is a first-line chemotherapeutic agent for oral cancer, but intrinsic and acquired resistance substantially limit its clinical efficacy. Epithelial–mesenchymal transition (EMT) has been associated with drug resistance across multiple tumor types; however, its involvement in cisplatin resistance in oral cancer remains incompletely understood. Here, we established an in vitro model of cisplatin resistance using the squamous cell carcinoma 9 (SCC-9) cell line and generated two populations with distinct resistance levels. We observed morphological and transcriptional changes consistent with EMT-related features, including increased mRNA expression of Vimentin, SNAIL1, ZEB1, ZEB2, and CDH2. Resistant cells also exhibited reduced proliferation, whereas the intermediately resistant population, cisplatin-resistant 4 (CPR4), showed greater wound closure, suggesting enhanced migratory behavior and features consistent with a hybrid-like EMT state. Conversely, the more resistant subline, cisplatin-resistant 8 (CPR8), exhibited a more stationary phenotype. Transcriptomic profiling by RNA sequencing (RNA-seq) revealed extensive differential gene expression associated with EMT and cisplatin resistance. Functional enrichment analyses identified Gene Ontology (GO) terms related to cell adhesion, extracellular matrix organization, and calcium ion binding, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed enrichment of PI3K/Akt signaling. Together, our findings support a dynamic model in which distinct EMT-related transcriptional states are associated with different levels of cisplatin resistance. This study provides insights into transcriptional changes associated with resistance acquisition and highlights candidate genes and pathways for further investigation and functional validation in oral cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmMouth NeoplasmsCarcinoma, Squamous CellTranscriptomeHumansCell Line, TumorEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticGene Expression ProfilingAntineoplastic AgentsSignal TransductionCell Proliferation

Stichwörter der Autor:innen

EMTRNA-Seqcisplatinoral cancerresistance

Substanzen

CisplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Laboratory of Molecular Biology, Department of Biosciences, Piracicaba Dental School, University of Campinas-UNICAMP, Piracicaba 13414-903, SP, Brazil.
  • Dental School, Nossa Senhora do Patrocínio Academic Center-CEUNSP, Itu 13300-200, SP, Brazil.
  • Department of Genetics, Institute of Biological Sciences, Federal University of Amazonas-UFAM, Manaus 69080-900, AM, Brazil.
  • Laboratory of Electrophysiology, Department of Neurobiology and Behavior, University of Campinas-UNICAMP, Campinas 13083-862, SP, Brazil.
  • Autoimmune Research Laboratory, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas-UNICAMP, Campinas 13083-862, SP, Brazil.
  • Life Sciences Core Facility (LaCTAD), University of Campinas-UNICAMP, Campinas 13083-886, SP, Brazil.

ORCID-Profile: Dieila Giomo de Lima, Felipe Luz Torres Silva, Gustavo Narvaes Guimarães, Ana Paula de Souza

Förderung

  • National Council for Scientific and Technological Development
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq

Zitieren

APA

Lima, D. G., Borgato, G. B., Silva, F. L. T., Vieira, A. S., Farias, A. S., Guimarães, G. N., & Souza, A. P. (2026). Comparative Transcriptomic Analysis of Oral Squamous Cell Carcinoma with Progressive Cisplatin Resistance. International Journal of Molecular Sciences, 27(16), 7366. https://doi.org/10.3390/ijms27167366

Vancouver

Lima DG, Borgato GB, Silva FLT, Vieira AS, Farias AS, Guimarães GN, et al. Comparative Transcriptomic Analysis of Oral Squamous Cell Carcinoma with Progressive Cisplatin Resistance. International Journal of Molecular Sciences. 2026;27(16):7366. doi:10.3390/ijms27167366

BibTeX
@article{Lima2026,
  author = {Lima, Dieila Giomo de and Borgato, Gabriell Bonifácio and Silva, Felipe Luz Torres and Vieira, André Schwambach and Farias, Alessandro Santos and Guimarães, Gustavo Narvaes and Souza, Ana Paula de},
  title = {Comparative Transcriptomic Analysis of Oral Squamous Cell Carcinoma with Progressive Cisplatin Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7366},
  doi = {10.3390/ijms27167366}
}
Kostenlos starten →